Skip to main content
SpringerLink
Log in
Book cover

Therapie von Leber- und Gallekrankheiten pp 217–280Cite as

Leberzirrhose und Komplikationen

  • Chapter

  • 26 Accesses

Zusammenfassung

Die Leberzirrhose ist eine chronische Leberkrankheit, die langsam entsteht und allmählich durch ständig zugrundegehendes Lebergewebe und dieses ersetzendes Bindegewebe zu irreversiblen Veränderungen führt. Auslöser des allmählichen Leberumbaus sind chronische Leberkrankheiten oder chronisch auf die Leber einwirkende Noxen. Betroffen ist immer das gesamte Organ. Die Krankheit kann asymptomatisch verlaufen oder mit wenigen uncharakteristischen oder auch starken Beschwerden einhergehen, die dann häufig auf lebensbedrohliche Komplikationen hinweisen. Die wichtigsten Komplikationen der Leberzirrhose sind der Aszites, die Ösophagusvarizenblutung und die hepatische Enzephalopathie.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Gerok W (1984) Leberzirrhose. In: Demling L (Hrsg) Klinische Gastroenterologie. Thieme, Stuttgart, New York, Bd II, S 115–151

    Google Scholar 

  • Gerok W (1981) Therapie der Protein– und Aminosäurenstoffwechselstörungen bei Leberkrankheiten. Leber-Magen-Darm 11: 63–72

    PubMed  CAS  Google Scholar 

  • Köllinger M, Kullmann F, Holstege A, Schölmerich J (1996) Prophylaxe und Therapie von Komplikationen der Leberzirrhose: Aszites, Enzephalopathie und Malnutrition. Med Klin 91: 89–102

    Google Scholar 

  • Melato M, Mucli E (1989) Something new in liver cirrhosis epidemiology. Lancet 2: 395–396

    Article  PubMed  CAS  Google Scholar 

  • Müller MJ, Lantz HU, Selberg O, Canzler H, Schmidt FW (1991) Ernährung bei chronischen Leberkrankheiten. Dtsch Med Wochenschr 116: 909–916

    Article  PubMed  Google Scholar 

  • Epstein FH, Post RS, McDowell M (1953) The effect of an arteriovenous fistula on renal he-modynamics and electrolyte excretion. J Clin Invest 32: 233–241

    Article  PubMed  CAS  Google Scholar 

  • Epstein M (1991) Renal disorders in liver disease. In: Suki WN, Massry SG (Hrsg.) Therapy of renal diseases and related disorders, 2nd edn. Kluwer, Dordrecht, S 477–493

    Chapter  Google Scholar 

  • Epstein M (1989) Treatment of refractory ascites. N Engl J Med 321: 220–228

    Google Scholar 

  • Nicholls KM, Shapiro MD, Groves BS, Schrier RW (1986) Factors determining renal response to water immersion in non-excretor cirrhotic patients. Kidney Int 30: 417–421

    Article  PubMed  CAS  Google Scholar 

  • Philipp T, Köhler H (1994) Gastrointestinale Systeme (einschließlich Leber). In: Brass H, Philipp T, Schulz W (Hrsg) Manuale Nephrologicum Dustri, Deisenhofen, VII 4/7, S 1–11

    Google Scholar 

  • Schrier RW, Caramelo C (1987) Hemodynamics and hormonal alterations in hepatic cirrhosis. In: Epstein M (Hrsg) The kidney in liver disease. Williams & Wilkins, New York

    Google Scholar 

  • Schrier RW (1988) Pathogenesis of sodium and water retention in high-output and low-out- put cardiac failure, nephrotic syndrome, cirrhosis and pregnancy. N Engl J Med 319: 1127–1134

    Article  PubMed  CAS  Google Scholar 

  • Epstein M (1982) Peritoneovenous shunt in the management of ascites and the hepatorenal

    Google Scholar 

  • syndrome. Gastroenterology 82:790–794

    Google Scholar 

  • Epstein M (1989) Treatment of refractory ascites. N Engl J Med 321: 1675–1677

    Article  PubMed  CAS  Google Scholar 

  • Gerbes AL, Paumgartner G (1994) Diagnostik des Aszites. Dtsch Med Wochenschr 119: 1507–1511

    Article  PubMed  CAS  Google Scholar 

  • Gerbes AL, Paumgartner G (1994) Therapie des Aszites bei Lebererkrankungen. Dtsch Med Wochenschr 119: 1549–1554

    Article  PubMed  CAS  Google Scholar 

  • Ginés P, Titó L, Arroyo Vet al. (1988) Randomized comparative study of therapeutic paracentesis with and without albumin in cirrhosis. Gastroenterology 94: 1493–1502

    PubMed  Google Scholar 

  • Pinzani M, Daskalopoulos G, Laffi G, Gentilini P, Zipser RD (1987) Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance. Gastroenterology 92: 294–298

    PubMed  CAS  Google Scholar 

  • Schölmerich J, Zimmermann U, Röttgen E et al. (1988) Proteases and antiproteases related to the coagulation system in plasma and ascites. Prediction of coagulation disorders in ascites retransfusion. J Hepatol 6: 359–363

    Google Scholar 

  • Schölmerich J (1991) Aszites. Pathophysiologic - Diagnostik - Therapie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Arroyo V, Navasa M, Rimola A (1994) Spontaneous bacterial peritonitis in liver cirrhosis:

    Google Scholar 

  • Treatment and prophylaxis. Infection 22 (Suppl. 3):167–175

    Google Scholar 

  • Cabre E, Gonzalez-Huix F, Abad-Lacruz A et al. (1990) Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. Gastroenterology 98: 715–720

    PubMed  CAS  Google Scholar 

  • Gilbert JA, Kamath PS (1995) Spontaneous bacterial peritonitis: An update. Mayo Clin Proc 70: 365–370

    Google Scholar 

  • Press AG, Meyer zum Büschenfelde KH, Ramadori G (1992) Die spontane bakterielle Perito¬nitis. Z Gastroenterol 30: 543–552

    PubMed  CAS  Google Scholar 

  • Rimola A, Navasa M, Arroyo V (1995) Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Diagn Microbiol Infect Dis 22: 141–145

    Article  PubMed  CAS  Google Scholar 

  • Rolando N, Harvey F, Brahm J et al. (1990) Prospective study of bacterial infection in acute liver failure: An analysis of fifty cases. Hepatology 11: 49–53

    Google Scholar 

  • Runyon BA, van Epps DE (1986) Diuresis of cirrhotic ascites increases its opsonic activity and may help prevent spontaneous bacterial peritonitis. Hepatology 6: 396–399

    Article  PubMed  CAS  Google Scholar 

  • Schölmerich J, Gerbes AL, Andus T, Leser H-G (1995) Spontane bakterielle Peritonitis bei Leberzirrhose mit Aszites. Dtsch Med Wochenschr 120: 454–461

    Article  PubMed  Google Scholar 

  • Soriano G, Guarner C, Teixido M et al. (1991) Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 100: 477–481

    PubMed  CAS  Google Scholar 

  • Tito L, Rimola A, Gines P et al. (1988) Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors. Hepatology 8: 27–31

    Google Scholar 

  • Angelico M, Carli L, Piat C et al. (1993) Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 104: 1460–1465

    PubMed  CAS  Google Scholar 

  • Besson I, Ingrand P, Person B et al. (1995) Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 333: 555–560

    Article  PubMed  CAS  Google Scholar 

  • Brocchi E, Caletti G, Brambilla G et al. (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319: 983–989

    Google Scholar 

  • Conn HO, Rambsby GR, Storer EH et al. (1975) Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective controlled clinical trial. Gastroenterology 68: 211–221

    PubMed  CAS  Google Scholar 

  • D’Amico G, Pagliaro L, Bosch J (1995) The treatment of portal hypertension: A meta-analytic review. Hepatology 22: 332–354

    Google Scholar 

  • Feretis C, Dimopoulos C, Benakis P, Kalliakmanis B, Apostolidis N (1995) N-butyl-2-cya- noacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy 27: 355–357

    Article  PubMed  CAS  Google Scholar 

  • Ganguly S, Sarin SK, Bhatia V, Lahoti D (1995) The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 21: 1226–1231

    PubMed  CAS  Google Scholar 

  • Grace ND (1992) Prevention of initial variceal hemorrhage. Gastroenterol Clin North Am 21: 149–161

    PubMed  CAS  Google Scholar 

  • Hashizume M, Kitano S, Koyanagi N (1992) Endoscopic injection sclerotherapy for 1000 patients with esophageal varices: A nine-year prospective study. Hepatology 15:69– 75

    Google Scholar 

  • Jutabha R, Jensen DM, See J, Machicado G, Hirabayashi K (1995) Randomized, controlled study of various agents for endoscopic injection sclerotherapy of bleeding canine gastric varices. Gastrointest Endosc 41: 206–211

    Article  PubMed  CAS  Google Scholar 

  • Kitano S, Terblanche J, Kahn D, Bornman PC (1986) Venous anatomy of the lower oesophagus in portal hypertension: Practical implication. Br J Surg 73: 525–531

    Google Scholar 

  • Kleber G, Sauerbruch T, Ansari H, Paumgartner G (1991) Prediction of variceal hemorrhage in cirrhosis: A prospective follow-up study. Gastroenterology 100: 1332–1337

    Google Scholar 

  • Lebrec D, Poynard T, Hillon P, Benhamou J (1981) Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 305: 1371–1374

    Article  PubMed  CAS  Google Scholar 

  • Orlof MJ, Orloff MS, Orlff SL, Haynes KS (1995) Treatment of bleeding from portal hypertensive gastropathy by portocaval shunt. Hepatology 21: 1011–1017

    Google Scholar 

  • Rigo GP, Merighi A, Chahin NJ et al. (1992) A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices. Gastrointest Endosc 38: 425–429

    Article  PubMed  CAS  Google Scholar 

  • Soehendra N, Nam VC, Grimm H, Kempeneers I (1986) Endoscopic obliteration of large esophageal varcies with bycrylate. Endoscopy 18: 25–26

    Article  PubMed  CAS  Google Scholar 

  • Stiegmann GV, Goff JS, Michaletz-Onody PA (1992) Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326:1527– 1532

    Google Scholar 

  • Thakeb F, Salama Z, Raouf TA, Kader SA, Hamid HA (1995) The value of combines use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding oeso- phagogastric varices. Endoscopy 27: 358–364

    Article  PubMed  CAS  Google Scholar 

  • The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988): Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A protective multicenter study. N Engl J Med 319: 983–989

    Article  Google Scholar 

  • Vianna A, Hayes PC, Moscoso G, Driver M, Portmann B, Westaby D, Williams R (1987) Normal venous circulation of the gastroesophageal junction: A route to understanding varices. Gastroenterology 93: 876–889

    Google Scholar 

  • Bizollon T (1991) Fibrinolytic therapy for portal vein thrombosis. Lancet 337: 1416

    Article  PubMed  CAS  Google Scholar 

  • Carmassi F, Morale M, De Negri F, Carrai M (1995) Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis. J Mol Med 73: 89–93

    Article  PubMed  CAS  Google Scholar 

  • DeCaterina MI, Tarantino G, Farina C (1993) Haemostasis unbalance in Pugh-scored liver cirrhosis; Characteristic changes of plasma levels of protein C versus Protein S. Haemostasis 23: 229

    Google Scholar 

  • Mammen EF (1994) Coagulopathies of liver disease. Clin Lab Med 14: 769–780

    PubMed  CAS  Google Scholar 

  • Mann O, Haag K, Hauenstein KH, Rössle M, Pausch J (1995) Septische Pfortaderthrombose. Dtsch Med Wochenschr 120: 1201–1206

    Article  PubMed  CAS  Google Scholar 

  • Mannucci PM, Vicente V, Vianello L (1986) Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 67: 1148

    PubMed  CAS  Google Scholar 

  • Scharrer I, Encke A, Hottenrott C (1988) Clinical cure of haemophilia A by liver transplantation. Lancet 1: 800–801

    Article  Google Scholar 

  • Scharrer I (1995) The need for highly purified products to treat hemophilia B. Acta Haematologica 94 (Suppl. l): 2–7

    Article  PubMed  Google Scholar 

  • Violi F, Ferro D, Basili S, Artini M, Valesini G, Levrero M, Cordova C (1995) Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationships to venous thrombosis. J Invest Med 43: 550–554

    Google Scholar 

  • Violi F, Ferro D, Basili S, Cimminiello C, Saliola M,Vezza E,Cordova C, and the CALC Group(1995) Prognostic value of clothing and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. Hepatology 22: 96–100

    Google Scholar 

  • Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA et al. (1991) Elevated brain concentrations of 1,4-benzodiazepine in fulminant hepatic failure. N Engl J Med 325: 473–478

    Article  PubMed  CAS  Google Scholar 

  • Butterworth RF (1995) Hepatic encephalopathy. Neurologist 1: 95–104

    Google Scholar 

  • Candranel JF, El Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D et al. (1995) Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study. Europ J Gastroenterol Hepatol 7: 325–329

    Google Scholar 

  • Charlton MR (1996) Branched chains revisited. Gastroenterology 111: 252–255

    Article  PubMed  CAS  Google Scholar 

  • Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seef L, Levy LL (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial. Gastroenterology 72: 573–583

    PubMed  CAS  Google Scholar 

  • Ferenci P, Püspök A, Steindl P (1992) Current concepts in the pathophysiology of hepatic

    Google Scholar 

  • encephalopathy. Eur J Clin Invest 22:573–581

    Google Scholar 

  • Gyr K, Meier R, Häussler J, Bouletreau P, Fleig WE, Gatta A et al (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomized, placebo controlled multicentre study. Gut 39: 319–324.

    Article  PubMed  CAS  Google Scholar 

  • Häussinger D, Maier KP (Hrsg) (1996) Hepatische Enzephalopathie. Thieme, Stuttgart

    Google Scholar 

  • Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M et al. (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 107: 1475–1480

    PubMed  Google Scholar 

  • Holstege A, Lock G, Köllinger M, Schölmerich J (1996) Conservative treatment of acute hepatic failure. Z Gastroenterologie 34: 192–201

    CAS  Google Scholar 

  • Kircheis G, Quack G, Erbler H (1994) L-ornithine-L-aspartate (OA) in the treatment of hyperammoniemia and hepatic encephalopathy - experimental aspects and clinical trials. In: Conn HO, Bircher J (Hrsg) Hepatic encephalopathy: Syndromes and therapies. Medi- Ed Press, Bloomington, S 373–383

    Google Scholar 

  • Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R et al (1997) Hepatology 25: 1351–1360

    Article  PubMed  CAS  Google Scholar 

  • Koch H, Schauder P, Schäfer G, Dahme B, Ebel W, Vahldiek B et al. (1990) Untersuchungen zur Diagnose und Prävalenz der latenten hepatischen Encephalopathie. Z Gastroenterolo¬gie 28: 610–615

    CAS  Google Scholar 

  • Köllinger M, Kullmann F, Holstege A, Schölmerich J (1996) Prophylaxe und Therapie von Komplikationen der Leberzirrhose: Aszites, Enzephalopathie und Malnutrition. Med Klin 91: 89–102

    Google Scholar 

  • Lee WM (1993) Acute liver failure. N Engl J Med 329: 1862–1872

    Article  PubMed  CAS  Google Scholar 

  • Lee WM (1995) Drug-induced hepatotoxicity. N Engl J Med 333: 1118–1127

    Article  PubMed  CAS  Google Scholar 

  • Naylor CD, O’Rorke K, Detsky AS, Baker JP (1989) Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 97: 1033–1042

    Google Scholar 

  • Pomier-Layrargues G, Giguere JF, Lavoie J, Perney P, Gagnon S, Damour M, Wells J, Butterworth RF (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomized double- blind placebo-controlled crossover trial. Hepatology 19: 32–37

    PubMed  CAS  Google Scholar 

  • Record CO (1991) Neurochemistry of hepatic encephalopathy. Gut 32: 1261–1263

    Article  PubMed  CAS  Google Scholar 

  • Riggio O, Balducci G, Ariosta F, Merli M, Temitera S, Ziparo V, Capocaccia L (1990) Lactitol in the treatment of chronic hepatic encephalopathy: a randomized cross-over comparison with lactulose. Hepatogastroenterol 37: 524–527

    CAS  Google Scholar 

  • Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G, Ziparo V, Pedrett G, Fiacca- dori F, Bottari E, Capocaccia L (1991) Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind cross-over trial. Dig Dis Sci 36: 1204–1208

    Google Scholar 

Download references

Authors
  1. U. Leuschner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Lenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Lembcke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Seifert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Scharrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Kircheis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W. F. Caspary
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum der Inneren Medizin Medizinische Klinik II, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Deutschland

    Wolfgang F. Caspary , Ulrich Leuschner  & Stefan Zeuzem ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Leuschner, U. et al. (1997). Leberzirrhose und Komplikationen. In: Caspary, W.F., Leuschner, U., Zeuzem, S. (eds) Therapie von Leber- und Gallekrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97978-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97978-1_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97979-8

  • Online ISBN: 978-3-642-97978-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation